PTC Therapeutics (PTCT) PT Raised to $85 at RBC Capital
Tweet
Share
E-mailGet Alerts PTCT Hot Sheet
Price: $78.45 +0.06%
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 22 | New: 24
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 22 | New: 24
Join SI Premium – FREE
RBC Capital analyst Brian Abrahams raised the price target on PTC Therapeutics (NASDAQ: PTCT) to $85.00 (from $82.00) while maintaining a Sector Perform rating.
You May Also Be Interested In
- PTC Therapeutics (PTCT) PT Lowered to $93 at Morgan Stanley
- Raymond James Upgrades Teck Resources Ltd (TECK-B:CN) (TECK) to Outperform
- Mobileye N.V (MBLY) PT Lowered to $12 at Canaccord
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
